Article metrics

Phase III, randomised, double-blind, placebo-controlled trial of Neuroaspis plp10 as an adjuvant treatment for relapsing multiple sclerosis: the MINERAL Study

 

Online download statistics by month:

Online download statistics by month: November 2022 to November 2022

AbstractFullPdf
Nov 2022496501130
Total496501130